Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 26, 2009
Reporting Period: The filing announces financial results for the three months and the full year ended December 31, 2008.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) for detailed figures. The filing text itself does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not contain specific data regarding material changes versus prior periods. It only confirms the issuance of results for the period ended December 31, 2008.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on February 26, 2009, detailing the results. The text explicitly states that the information in Item 2.02 and the attached press release is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section.
Guidance and Risks: No specific guidance, outlook, risks, contingencies, or unusual items are described in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net income, and cash flow figures for Q4 and FY 2008.
- Verify year-over-year percentage changes in key metrics as detailed in the press release.
- Check for any forward-looking statements or guidance included in the press release that are not present in this 8-K summary.
- Confirm the status of the company's liquidity and debt obligations as reported in the full financial statements referenced by the press release.